<DOC>
	<DOCNO>NCT02993653</DOCNO>
	<brief_summary>Definitive treatment protocol high-dose intensity-modulated radiotherapy ( IMRT ) intracavitary radiotherapy locally advanced cervical cancer : A phase II trial</brief_summary>
	<brief_title>Intensity-modulated Radiotherapy Protocol Cervix Cancer</brief_title>
	<detailed_description>Radiotherapy 1. intensity-modulated radiotherapy whole pelvis : 60 Gy 30 fx Re-simulation pelvic Magnetic resonance image 46 Gy 23 fx intensity-modulated radiotherapy gross cervical nodal tumor ( initially Positron emission tomography-positive ) , 14 Gy 7 fx 2. intensity-modulated radiotherapy boost gross cervical tumor Intra-cavitary radiotherapy ( ICR ) - Re-staging pelvic Magnetic resonance imaging , complete response occur Intra-cavitary radiotherapy A point , 25 Gy 5 fx 2 week - Re-staging pelvic Magnetic resonance imaging I , partial response stable disease occur intensity-modulated radiotherapy boost , 10 Gy 4 fx gross cervical tumor 1 week</detailed_description>
	<criteria>1 . FIGO IIIVA Patients untreated histologically confirm carcinoma uterine cervix 2 . Patients Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 , 1 3 . Patients adequate bone marrow function : Absolute nutrophil count ( ANC ) great equal 1,500/mcl , platelet great equal 100,000/mcl begin 4 . Patients adequate renal function : creatinine equal less 2.0 mg/mL 5 . Patients sign approve informed consent authorization 1 . Patients recurrent cervical cancer 2 . Patients diagnosis malignance tumor except papillary follicular thyroid cancer skin cancer 3 . Patients metastatic lymphadenopathy pelvis ( e.g . inguinal , paraaortic , supraclavicular , mediastinal node ) 4 . Patients distant organ metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>